Advertisement
IRMD vs PHG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a StrongBuy and PHG is a Hold.
IRMD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for IRMD turned positive on November 06, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IRMD's RSI Oscillator exited the oversold zone, 12 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IRMD as a result. In 86 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
IRMD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 194 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 203 of 260 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.847) is normal, around the industry mean (4.142). P/E Ratio (47.685) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).
PHG in upward trend: price rose above 50-day moving average on October 20, 2026
PHG moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on PHG as a result. In 51 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for PHG just turned positive on October 08, 2026. Looking at past instances where PHG's MACD turned positive, the stock continued to rise in 32 of 48 cases over the following month. The odds of a continued upward trend are 67%.
The 10-day moving average for PHG crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +12.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHG advanced for three days, in 205 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 109 of 201 cases where PHG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 21 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
PHG broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.592) is normal, around the industry mean (4.142). P/E Ratio (25.940) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.768) is also within normal values, averaging (11.253). PHG has a moderately high Dividend Yield (0.134) as compared to the industry average of (0.011). P/S Ratio (1.175) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. PHG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IRMD | PHG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 20 | 100 | |
SMR RATING 1..100 | 41 | 69 | |
PRICE GROWTH RATING 1..100 | 56 | 39 | |
P/E GROWTH RATING 1..100 | 55 | 96 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (9) in the Electronic Production Equipment industry is significantly better than the same rating for IRMD (85) in the Medical Specialties industry. This means that PHG’s stock grew significantly faster than IRMD’s over the last 12 months.
IRMD's Profit vs Risk Rating (20) in the Medical Specialties industry is significantly better than the same rating for PHG (100) in the Electronic Production Equipment industry. This means that IRMD’s stock grew significantly faster than PHG’s over the last 12 months.
IRMD's SMR Rating (41) in the Medical Specialties industry is in the same range as PHG (69) in the Electronic Production Equipment industry. This means that IRMD’s stock grew similarly to PHG’s over the last 12 months.
PHG's Price Growth Rating (39) in the Electronic Production Equipment industry is in the same range as IRMD (56) in the Medical Specialties industry. This means that PHG’s stock grew similarly to IRMD’s over the last 12 months.
IRMD's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for PHG (96) in the Electronic Production Equipment industry. This means that IRMD’s stock grew somewhat faster than PHG’s over the last 12 months.
| IRMD | PHG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 55% |
| Momentum ODDS (%) | 1 day ago 75% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 79% | 3 days ago 67% |
| TrendWeek ODDS (%) | 1 day ago 65% | 1 day ago 60% |
| TrendMonth ODDS (%) | 1 day ago 67% | 1 day ago 56% |
| Advances ODDS (%) | 3 days ago 73% | 8 days ago 66% |
| Declines ODDS (%) | 1 day ago 60% | 1 day ago 65% |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRMD’s FA Score shows that 1 FA rating(s) are green while PHG’s FA Score has 1 green FA rating(s).
- IRMD’s FA Score: 1 green, 4 red.
- PHG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRMD’s TA Score shows that 7 TA indicator(s) are bullish while PHG’s TA Score has 6 bullish TA indicator(s).
- IRMD’s TA Score: 7 bullish, 3 bearish.
- PHG’s TA Score: 6 bullish, 4 bearish.
Price Growth
IRMD (@Medical/Nursing Services) experienced а +6.92% price change this week, while PHG (@Medical/Nursing Services) price change was -2.77% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
IRMD is expected to report earnings on Feb 04, 2027.
PHG is expected to report earnings on Feb 01, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
IRMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with PHG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then PHG could also see price increases.
| Ticker / NAME | Correlation To IRMD | 1D Price Change % | ||
|---|---|---|---|---|
| IRMD | 100% | -0.16% | ||
| PHG - IRMD | 48% Loosely correlated | -0.69% | ||
| HBIO - IRMD | 45% Loosely correlated | +4.54% | ||
| ATEC - IRMD | 44% Loosely correlated | +5.00% | ||
| LIVN - IRMD | 43% Loosely correlated | -0.18% | ||
| TCMD - IRMD | 42% Loosely correlated | +1.92% | ||
More | ||||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with GEHC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then GEHC could also see price increases.